- Investing Ideas
- Belgian Pharmaceuticals & Biotech Most Popular Stocks
Belgian Pharmaceuticals & Biotech Most Popular Stocks
Results
7
Most Popular Stocks on the market
7 companies
argenx
Market Cap: €51.3b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€830.80
7D
5.9%
1Y
77.9%
UCB
Market Cap: €50.4b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€259.50
7D
0.4%
1Y
53.6%
Financière de Tubize
Market Cap: €10.1b
Financière de Tubize SA holds a stake in UCB, a biopharmaceutical company in Belgium.
TUB
€224.40
7D
-0.4%
1Y
67.5%
Hyloris Pharmaceuticals
Market Cap: €125.4m
Operates as a specialty pharmaceutical company in Belgium, the United States, Europe, the Middle East, Africa, and Asia-Pacific.
HYL
€4.52
7D
-2.8%
1Y
-28.0%
Celyad Oncology
Market Cap: €10.5m
A biotechnology company, focuses on unlocking the potential of its intellectual property.
CYAD
€0.23
7D
-6.4%
1Y
-37.3%
BioSenic
Market Cap: €1.3m
A biotechnology company, develops cell therapy products and treatments for autoimmune and inflammatory diseases in Belgium and France.
BIOS
€0.002
7D
0%
1Y
-13.0%
Oxurion
Market Cap: €266.1k
A biopharmaceutical company, develops medicines for vascular retinal disorder in Belgium.
OXUR
€0.003
7D
7.1%
1Y
-89.7%